Edit |   |
---|---|
Antigenic Specificity | SARS-CoV-2 RBD (Etesevimab biosimilar) |
Clone | Etesevimab (JS016) |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | Human IgG |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-SARS-CoV-2 RBD Recombinant Antibody (Etesevimab (JS016)). Bamlanivimab/etesevimab is a combination of two monoclonal antibodies, bamlanivimab and etesevimab, administered together via intravenous infusion as a treatment for COVID-19. Both types of antibody target the surface spike protein of SARS CoV 2. |
Immunogen | n/a |
Other Names | Anti-RBD Recombinant Antibody, Research Grade Etesevimab(JS016), Anti-SARS-CoV-2 RBD Recombinant Antibody(Etesevimab(JS016)), LY-CoV016, Antibody Drug Analogues, Monoclonal Antibody, YR1635, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | n/a |
Catalog # | YR1635 |
Price | please inquire |
Order / More Info | SARS-CoV-2 RBD (Etesevimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |